EX-FILING FEES 4 tm2226895d2_ex-filingfees.htm EX-FILING FEES

 

Exhibit 107

 

Calculation of Filing Fee Tables

Form S-1

(Form Type)

First Wave BioPharma, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

    Security
Type
  Security Class Title   Fee
Calculation or
Carry
Forward Rule
  Amount
Registered
  Proposed
Maximum
Offering
Price Per
Unit
  Maximum
Aggregate
Offering
Price(1)
    Fee Rate     Amount of
Registration
Fee
 
Fees to Be Paid   Equity   Shares of common stock, par value $0.0001 per share (2)(3)   457(o)   -   -   $ 12,000,000.00       0.0000927     $ 1,112.40  
Fees to Be Paid   Equity   Common Warrants   457(g)   --   -     -       -       (4 )
Fees to Be Paid   Equity   Pre-Funded Warrants (3)   457(g)   -   -     -       -       (4 )
Fees to Be Paid   Equity   Shares of common stock, par value $0.0001 per share (2)(5)   457(o)   -   -   $ 12,000,000.00       0.0000927     $ 1,112.40  
Fees to Be Paid   Equity   Shares of common stock, par value $0.0001 per share(2)(3)(6)   457(o)   -   -     (3 )     0.0000927       (3 )
    Total Offering Amounts       $ 24,000,000.00             $ 2,224.80  
    Total Fees Previously Paid                         2,224.80  
    Total Fee Offsets                         -  
    Net Fee Due                       $ 0  

 

  (1) Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).

 

  (2) Pursuant to Rule 416(a) under the Securities Act of 1933, this registration statement shall also cover an indeterminate number of shares that may be issued and resold resulting from stock splits, stock dividends or similar transactions.

 

  (3) The proposed maximum aggregate offering price of the common stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any common stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the common stock and pre-funded warrants (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $12,000,000.00.

 

  (4) No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act.

 

  (5) Shares of common stock issuable upon the exercise of the Common Warrants.

 

  (6) Shares of common stock issuable upon exercise of the Pre-Funded Warrants.